460 related articles for article (PubMed ID: 27531481)
21. Incidence and Impact of Pretreatment Tumor Cavitation on Survival Outcomes of Stage III Squamous Cell Lung Cancer Patients Treated With Radical Concurrent Chemoradiation Therapy.
Topkan E; Selek U; Ozdemir Y; Yildirim BA; Guler OC; Ciner F; Besen AA; Findikcioglu A; Ozyilkan O
Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1123-1132. PubMed ID: 29887509
[TBL] [Abstract][Full Text] [Related]
22. The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-Analysis.
You R; Cao YS; Huang PY; Chen L; Yang Q; Liu YP; Zou X; Zhang YN; Jiang R; Zhang MX; Duan CY; Lin AH; Hong MH; Chen MY
Theranostics; 2017; 7(19):4825-4835. PubMed ID: 29187906
[No Abstract] [Full Text] [Related]
23. Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis.
Zhang B; Mo Z; Du W; Wang Y; Liu L; Wei Y
Oral Oncol; 2015 Nov; 51(11):1041-1046. PubMed ID: 26296274
[TBL] [Abstract][Full Text] [Related]
24. [Comparison of the application among intensity-modulated radiotherapy, 3D-conformal radiotherapy and conventional radiotherapy for locally advanced middle-low rectal cancer].
Zhang C; Dong J; Shen T; Li Y; Yang Z; Cheng X; Luo H; Yang J; Shi Z; Wang W; Zhang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1414-1420. PubMed ID: 30588595
[TBL] [Abstract][Full Text] [Related]
25. Impact of weight change during the course of concurrent chemoradiation therapy on outcomes in stage IIIB non-small cell lung cancer patients: retrospective analysis of 425 patients.
Topkan E; Parlak C; Selek U
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):697-704. PubMed ID: 24035331
[TBL] [Abstract][Full Text] [Related]
26. Association between intensity modulated radiotherapy and survival in patients with stage III non-small cell lung cancer treated with chemoradiotherapy.
Koshy M; Malik R; Spiotto M; Mahmood U; Rusthoven CG; Sher DJ
Lung Cancer; 2017 Jun; 108():222-227. PubMed ID: 28625640
[TBL] [Abstract][Full Text] [Related]
27. Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided, Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-Small Cell Lung Cancer.
Chi A; Wen S; Monga M; Almubarak M; He X; Rojanasakul Y; Tse W; Remick SC
PLoS One; 2016; 11(9):e0162453. PubMed ID: 27611833
[TBL] [Abstract][Full Text] [Related]
28. Propensity score-based comparison of survival and radiation pneumonitis after definitive chemoradiation for esophageal cancer: Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy.
Lan K; Zhu J; Zhang J; Zhou S; Yang Y; Feng Z; Zhang L; Wang S; Xi M
Radiother Oncol; 2020 Aug; 149():228-235. PubMed ID: 32474127
[TBL] [Abstract][Full Text] [Related]
29. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
[TBL] [Abstract][Full Text] [Related]
30. Improved oncologic outcomes with image-guided intensity-modulated radiation therapy using helical tomotherapy in locally advanced hepatocellular carcinoma.
Yoon HI; Lee IJ; Han KH; Seong J
J Cancer Res Clin Oncol; 2014 Sep; 140(9):1595-605. PubMed ID: 24809934
[TBL] [Abstract][Full Text] [Related]
31. Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphoma.
Filippi AR; Ciammella P; Piva C; Ragona R; Botto B; Gavarotti P; Merli F; Vitolo U; Iotti C; Ricardi U
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):370-5. PubMed ID: 24613810
[TBL] [Abstract][Full Text] [Related]
32. Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis.
Xi M; Xu C; Liao Z; Chang JY; Gomez DR; Jeter M; Cox JD; Komaki R; Mehran R; Blum MA; Hofstetter WL; Maru DM; Bhutani MS; Lee JH; Weston B; Ajani JA; Lin SH
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):667-676. PubMed ID: 29280461
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of weight gain during definitive chemoradiotherapy for locally advanced non-small-cell lung cancer.
Sher DJ; Gielda BT; Liptay MJ; Warren WH; Batus M; Fidler MJ; Garg S; Bonomi P
Clin Lung Cancer; 2013 Jul; 14(4):370-5. PubMed ID: 23260389
[TBL] [Abstract][Full Text] [Related]
34. Feasibility and efficacy of helical intensity-modulated radiotherapy for stage III non-small cell lung cancer in comparison with conventionally fractionated 3D-CRT.
He J; Huang Y; Chen Y; Shi S; Ye L; Hu Y; Zhang J; Zeng Z
J Thorac Dis; 2016 May; 8(5):862-71. PubMed ID: 27162660
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes and toxicity of postoperative intensity-modulated versus three-dimensional conformal radiation therapy in patients with cervical cancer.
Lan ML; Yu X; Xiao H; Zhou P; Hu N; Li J; Wang G
Asia Pac J Clin Oncol; 2016 Dec; 12(4):430-436. PubMed ID: 26923341
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer.
Ling DC; Hess CB; Chen AM; Daly ME
Clin Lung Cancer; 2016 Jan; 17(1):18-23. PubMed ID: 26303127
[TBL] [Abstract][Full Text] [Related]
37. Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experience.
Desai NB; Stein NF; LaQuaglia MP; Alektiar KM; Kushner BH; Modak S; Magnan HM; Goodman K; Wolden SL
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e67-72. PubMed ID: 23084475
[TBL] [Abstract][Full Text] [Related]
38. Comparative outcomes for three-dimensional conformal versus intensity-modulated radiation therapy for esophageal cancer.
Freilich J; Hoffe SE; Almhanna K; Dinwoodie W; Yue B; Fulp W; Meredith KL; Shridhar R
Dis Esophagus; 2015; 28(4):352-7. PubMed ID: 24635657
[TBL] [Abstract][Full Text] [Related]
39. Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areas.
Ohnleiter T; Antoni D; Lefebvre F; Truntzer P; Schultz P; Burgy M; Borel C; Noël G
Chin Clin Oncol; 2018 Dec; 7(6):60. PubMed ID: 30180748
[TBL] [Abstract][Full Text] [Related]
40. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]